These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 14594287)

  • 1. Gadolinium-binding helix-turn-helix peptides: DNA-dependent MRI contrast agents.
    Caravan P; Greenwood JM; Welch JT; Franklin SJ
    Chem Commun (Camb); 2003 Oct; (20):2574-5. PubMed ID: 14594287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein-targeted gadolinium-based magnetic resonance imaging (MRI) contrast agents: design and mechanism of action.
    Caravan P
    Acc Chem Res; 2009 Jul; 42(7):851-62. PubMed ID: 19222207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gadolinium(III) di- and tetrachelates designed for in vivo noncovalent complexation with plasma proteins: a novel molecular design for blood pool MRI contrast enhancing agents.
    Martin VV; Ralston WH; Hynes MR; Keana JF
    Bioconjug Chem; 1995; 6(5):616-23. PubMed ID: 8974462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-relaxivity MRI contrast agents: where coordination chemistry meets medical imaging.
    Werner EJ; Datta A; Jocher CJ; Raymond KN
    Angew Chem Int Ed Engl; 2008; 47(45):8568-80. PubMed ID: 18825758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymeric gadolinium chelate magnetic resonance imaging contrast agents: design, synthesis, and properties.
    Ladd DL; Hollister R; Peng X; Wei D; Wu G; Delecki D; Snow RA; Toner JL; Kellar K; Eck J; Desai VC; Raymond G; Kinter LB; Desser TS; Rubin DL
    Bioconjug Chem; 1999; 10(3):361-70. PubMed ID: 10346865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A DNA-binding Gd chelate for the detection of cell death by MRI.
    Garanger E; Hilderbrand SA; Blois JT; Sosnovik DE; Weissleder R; Josephson L
    Chem Commun (Camb); 2009 Aug; (29):4444-6. PubMed ID: 19597620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of a binary chelate formulation: Could gadolinium based linear contrast agents be rescued by the addition of zinc selective chelates?
    Gibby W; Parish W; Merrill RM; Fernandez D; Anderson CR; Merchel E; Parr R
    Magn Reson Imaging; 2019 May; 58():76-81. PubMed ID: 30639754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MS-325: albumin-targeted contrast agent for MR angiography.
    Lauffer RB; Parmelee DJ; Dunham SU; Ouellet HS; Dolan RP; Witte S; McMurry TJ; Walovitch RC
    Radiology; 1998 May; 207(2):529-38. PubMed ID: 9577506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gadolinium meets medicinal chemistry: MRI contrast agent development.
    Zhang Z; Nair SA; McMurry TJ
    Curr Med Chem; 2005; 12(7):751-78. PubMed ID: 15853710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of High Relaxivity Gadolinium AAZTA Tetramers as Building Blocks for Bioconjugation.
    Tripepi M; Capuana F; Gianolio E; Kock FVC; Pagoto A; Stefania R; Digilio G; Aime S
    Bioconjug Chem; 2018 Apr; 29(4):1428-1437. PubMed ID: 29470084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of relaxivity rates of Gd-DTPA complexes by intercalation into layered double hydroxide nanoparticles.
    Xu ZP; Kurniawan ND; Bartlett PF; Lu GQ
    Chemistry; 2007; 13(10):2824-30. PubMed ID: 17186555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Densely packed Gd(III)-chelates with fast water exchange on a calix[4]arene scaffold: a potential MRI contrast agent.
    Schühle DT; Polásek M; Lukes I; Chauvin T; Tóth E; Schatz J; Hanefeld U; Stuart MC; Peters JA
    Dalton Trans; 2010 Jan; (1):185-91. PubMed ID: 20023949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategies for increasing the sensitivity of gadolinium based MRI contrast agents.
    Caravan P
    Chem Soc Rev; 2006 Jun; 35(6):512-23. PubMed ID: 16729145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new nonionic macrocyclic gadolinium(III) chelate as a potential magnetic-resonance-imaging contrast agent.
    Inoue MB; Oram P; Inoue M; Fernando Q; Alexander AL; Unger EC
    Magn Reson Imaging; 1994; 12(3):429-32. PubMed ID: 8007772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rational design of protein-based MRI contrast agents.
    Yang JJ; Yang J; Wei L; Zurkiya O; Yang W; Li S; Zou J; Zhou Y; Maniccia AL; Mao H; Zhao F; Malchow R; Zhao S; Johnson J; Hu X; Krogstad E; Liu ZR
    J Am Chem Soc; 2008 Jul; 130(29):9260-7. PubMed ID: 18576649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gadolinium(III) 1,2-hydroxypyridonate-based complexes: toward MRI contrast agents of high relaxivity.
    Xu J; Churchill DG; Botta M; Raymond KN
    Inorg Chem; 2004 Sep; 43(18):5492-4. PubMed ID: 15332797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-EpCAM scFv gadolinium chelate: a novel targeted MRI contrast agent for imaging of colorectal cancer.
    Khantasup K; Saiviroonporn P; Jarussophon S; Chantima W; Dharakul T
    MAGMA; 2018 Oct; 31(5):633-644. PubMed ID: 29737435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relaxometric evaluation of novel manganese(II) complexes for application as contrast agents in magnetic resonance imaging.
    Aime S; Anelli L; Botta M; Brocchetta M; Canton S; Fedeli F; Gianolio E; Terreno E
    J Biol Inorg Chem; 2002 Jan; 7(1-2):58-67. PubMed ID: 11862541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GdIII complexes with fast water exchange and high thermodynamic stability: potential building blocks for high-relaxivity MRI contrast agents.
    Laus S; Ruloff R; Tóth E; Merbach AE
    Chemistry; 2003 Aug; 9(15):3555-66. PubMed ID: 12898682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lanthanide-binding helix-turn-helix peptides: solution structure of a designed metallonuclease.
    Welch JT; Kearney WR; Franklin SJ
    Proc Natl Acad Sci U S A; 2003 Apr; 100(7):3725-30. PubMed ID: 12644701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.